Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
about
Need for a paradigm shift in therapeutic approaches to CNS injuryIs Multiple Sclerosis an Autoimmune Disease?Biomarkers of treatment response in multiple sclerosisUncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological eventAlpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitopeSerum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan arrayCompetition between serum IgG, IgM, and IgA anti-glycan antibodiesEvidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosisToward biomarkers in multiple sclerosis: new advances.Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum.Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis.Anti-glycan antibodies as biomarkers for diagnosis and prognosis.New serological biomarkers of inflammatory bowel disease.Profiling human serum antibodies with a carbohydrate antigen microarray.B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.Immunotherapy of multiple sclerosis: the state of the art.
P2860
Q27025042-F230B8CB-3F04-4323-8251-7F26FB3E3370Q27496011-D5A2D782-DD38-478B-A05A-07480B0D512BQ28305094-4A6A7003-C88A-4700-8479-CA06F0EA2E5EQ33605256-61469A0A-18BC-4E33-8076-644F83655C8DQ33773528-E097F19E-07ED-4C63-A49B-AEA44003FDE9Q34471650-3259AA13-21D8-454E-BFA0-F38C207010ACQ34652734-F01BAF11-2131-4516-96D0-5BBCD1E1AB66Q35109145-EBABABDA-D60F-4B0D-9294-3DB58F4478CBQ35217313-34F59E11-BA48-4DB9-873C-2CEA22124401Q35231795-DFE3D253-7659-4BEF-86FE-6FE2CE662802Q36492380-78F7D47E-D665-4282-92C3-D14A5176A162Q36499916-DDF64FA2-54EB-4345-9CAD-4190EE835585Q36538190-EEE3700E-38DE-4064-AAEF-98659527C296Q36560795-52987296-C248-4666-A3D1-C05536059A8DQ37262989-1B9E51F0-575E-498D-A92D-9E87D2EA8B38Q37335054-581D6F92-42C1-4F5A-8053-BE7C91660403Q38018052-EF542210-16FB-478B-B6B6-1B9C83019384Q38083041-65375069-EA69-49D2-A658-04DBEF0B8158
P2860
Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Serum anti-Glc(alpha1,4)Glc(al ...... -remitting multiple sclerosis.
@ast
Serum anti-Glc(alpha1,4)Glc(al ...... -remitting multiple sclerosis.
@en
type
label
Serum anti-Glc(alpha1,4)Glc(al ...... -remitting multiple sclerosis.
@ast
Serum anti-Glc(alpha1,4)Glc(al ...... -remitting multiple sclerosis.
@en
prefLabel
Serum anti-Glc(alpha1,4)Glc(al ...... -remitting multiple sclerosis.
@ast
Serum anti-Glc(alpha1,4)Glc(al ...... -remitting multiple sclerosis.
@en
P2093
P921
P1476
Serum anti-Glc(alpha1,4)Glc(al ...... -remitting multiple sclerosis.
@en
P2093
Ariel Miller
Arnon Karni
Larissa Spector
Lea Glass-Marmor
Mikael Schwarz
Monica Gortler
Oori Weisshaus
P356
10.1016/J.JNS.2005.12.006
P577
2006-02-09T00:00:00Z